Inhibitors & Activators for Regenerative Medicine Research
Inhibitors and activators serve as indispensable tools in regenerative medicine research, offering precise control over cellular pathways and biological functions. These compounds are pivotal in elucidating signaling cascades, regulating cellular responses, and exploring therapeutic strategies aimed at harnessing the body's regenerative potential.
Salmeterol xinafoate, beta2 adrenoceptor agonist (RMML-00120945)
Target Pathways : beta2 adrenoceptor
CAS Number : 94749-08-3
Source : Synthetic
Purity : > 96%
TBB, casein kinase-2 (CK2) inhibitor (RMML-00120944)
Target Pathways : CK2
CAS Number : 17374-26-4
Source : Synthetic
Purity : > 98%
Histone Acetyltransferase Inhibitor II, p300/CBP HAT inhibitor (RMML-00120943)
Target Pathways : p300/CBP HAT
CAS Number : 932749-62-7
Source : Synthetic
Purity : > 98%
SU 5416 (Semaxanib), VEGFR-2 inhibitor (RMML-00120942)
Target Pathways : VEGFR2
CAS Number : 204005-46-9
Source : Synthetic
Purity : > 99%
SU 1498, VEGFR2 inhibitor (RMML-00120941)
Target Pathways : VEGFR2
CAS Number : 168835-82-3
Source : Synthetic
Purity : > 99%
SU 1498, VEGFR2 inhibitor (RMML-00120940)
Target Pathways : VEGFR2
CAS Number : 168835-82-3
Source : Synthetic
Purity : > 99%
Finasteride, Type II 5alpha-reductase inhibitor (RMML-00120939)
Target Pathways : Type II 5alpha-reductase
CAS Number : 98319-26-7
Source : Synthetic
Purity : > 99%
AG-879, TrkA receptor inhibitor (RMML-00120938)
Target Pathways : TrkA receptor
CAS Number : 148741-30-4
Source : Synthetic
Purity : > 99%
RepSox, TGF-beta type 1 receptor inhibitor (RMML-00120937)
Target Pathways : TGF-beta type 1 receptor
CAS Number : 446859-33-2
Source : Synthetic
Purity : > 98%
RepSox, TGF-beta type 1 receptor inhibitor (RMML-00120936)
Target Pathways : TGF-beta type 1 receptor
CAS Number : 446859-33-2
Source : Synthetic
Purity : > 98%
Stattic, STAT3 inhibitor (RMML-00120935)
Target Pathways : STAT3
CAS Number : 19983-44-9
Source : Synthetic
Purity : > 99%
Stattic, STAT3 inhibitor (RMML-00120934)
Target Pathways : STAT3
CAS Number : 19983-44-9
Source : Synthetic
Purity : > 99%
Y-27632 dihydrochloride, Rho kinase inhibitor (RMML-00120933)
Target Pathways : Rho kinase
CAS Number : 129830-38-2
Source : Synthetic
GW 9662, PPARgamma antagonist (RMML-00120932)
Target Pathways : PPAR-gamma
CAS Number : 22978-25-2
Source : Synthetic
Purity : > 99%
Ciglitazone, PPARgamma agonist (RMML-00120931)
Target Pathways : PPAR-gamma
CAS Number : 74772-77-3
Source : Synthetic
Purity : > 98%
For research use only. Not for clinical use.